Cargando…

Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease

BACKGROUND: Circulating miRNAs have momentous clinical relevance as prognostic biomarkers and in the progression of solid tumors. Recognizing novel candidates of neuroblastoma-specific circulating miRNAs would allow us to identify potential prognostic biomarkers that could predict the switch from fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramraj, Satish Kumar, Aravindan, Sheeja, Somasundaram, Dinesh Babu, Herman, Terence S., Natarajan, Mohan, Aravindan, Natarajan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951313/ https://www.ncbi.nlm.nih.gov/pubmed/26921195 http://dx.doi.org/10.18632/oncotarget.7615

Ejemplares similares

MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
por: Aravindan, Natarajan, et al.
Publicado: (2019)

Cancer stem cells in neuroblastoma therapy resistance
por: Aravindan, Natarajan, et al.
Publicado: (2019)

Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells
por: Khan, Faizan H, et al.
Publicado: (2015)

Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer
por: Aravindan, Sheeja, et al.
Publicado: (2015)

De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019)

Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells
por: Aravindan, Sheeja, et al.
Publicado: (2016)

RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes
por: Khan, Faizan H., et al.
Publicado: (2015)

Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes
por: Khan, Faizan H., et al.
Publicado: (2015)

Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer
por: Aravindan, Sheeja, et al.
Publicado: (2015)

Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
por: Somasundaram, Dinesh Babu, et al.
Publicado: (2019)

Novel Synthetic Monoketone Transmute Radiation-Triggered NFκB-Dependent TNFα Cross-Signaling Feedback Maintained NFκB and Favors Neuroblastoma Regression
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Molecular basis of ‘hypoxic’ breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Anti-Pancreatic Cancer Deliverables from Sea: First-Hand Evidence on the Efficacy, Molecular Targets and Mode of Action for Multifarious Polyphenols from Five Different Brown-Algae
por: Aravindan, Sheeja, et al.
Publicado: (2013)

Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights
por: Aravindan, Sheeja, et al.
Publicado: (2017)

Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling
por: Pandian, Vijayabaskar, et al.
Publicado: (2015)

Erratum to: Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling
por: Pandian, Vijayabaskar, et al.
Publicado: (2016)

High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice: Insight into the Connection between Activation of Oncotargets and Oncogene Addiction
por: Aravindan, Natarajan, et al.
Publicado: (2016)

Irreversible EGFR Inhibitor EKB-569 Targets Low-LET γ-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma
por: Aravindan, Natarajan, et al.
Publicado: (2011)

Regulation of DNA repair by non-coding miRNAs
por: Natarajan, Venkateswaran
Publicado: (2016)

New miRNAs cloned from neuroblastoma
por: Afanasyeva, Elena A, et al.
Publicado: (2008)

The role of epigenetics and miRNAs in neuroblastoma development
por: Rupani, KV, et al.
Publicado: (2012)

Identification of miRNAs contributing to neuroblastoma chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2015)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

Mapping circulating serum miRNAs to their immune-related target mRNAs
por: Nosirov, Bakhtiyor, et al.
Publicado: (2017)

Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma
por: Maugeri, Marco, et al.
Publicado: (2016)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy
por: Griffith, James, et al.
Publicado: (2017)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis
por: Chen, Guansheng, et al.
Publicado: (2023)

An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance
por: Carta, Alessia, et al.
Publicado: (2014)

Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases
por: Takada, Yukichi, et al.
Publicado: (2021)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
por: Bray, Isabella, et al.
Publicado: (2009)

Identification of Ovarian Cancer Metastatic miRNAs
por: Vang, Souriya, et al.
Publicado: (2013)

PAmiRDB: A web resource for plant miRNAs targeting viruses
por: Satish, Deepshikha, et al.
Publicado: (2019)

MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients
por: Withers, Sarah B., et al.
Publicado: (2020)

Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m53ckaqsi6fgf8q6vrt36v36os